APO Research
Talk to an analyst

APO RESEARCH · REPORT

Statin Industry

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Statin Industry Industry Growth and Trends Forecast to 2032

28 December 2025112 pages

Choose your research edition.

Industry ResearchStatin Industry Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Statin Industry Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Statin Industry Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Statin Industry Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Statin Industry Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

According to APO Research, the global Statin Industry market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Statin Industry is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Statin Industry is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Statin Industry is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Statin Industry market include CHIA TAI TIANQING, Zhejiang Jingxin Pharmaceutical, Shanghai Shyndec Pharmaceutical, Henan Topfond Pharmaceutical, Novartis, Merck, LUNAN BETTER, Livzon Pharmaceutical and Wanbang Biopharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Statin Industry market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Statin Industry market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Statin Industry market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Statin Industry.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Statin Industry market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Statin Industry Market by Company

CHIA TAI TIANQING

Zhejiang Jingxin Pharmaceutical

Shanghai Shyndec Pharmaceutical

Henan Topfond Pharmaceutical

Novartis

Merck

LUNAN BETTER

Livzon Pharmaceutical

Wanbang Biopharmaceuticals

Pfizer

Huizhi

China Resources Double-Crane Pharmaceutical

North China Pharmaceutical

Hanhui Pharmaceutical

Daiichi Sankyo

Beijing Jialin Pharmaceutical

AstraZeneca

Statin Industry Segment by Type

Astrovastatin

Pitavastatin

Rosuvastatin

Others

Statin Industry Segment by Application

Inflammatory Disorders

Cardiovascular Disorders

Obesity

Others

Statin Industry Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Statin Industry market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Statin Industry and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Statin Industry.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Statin Industry companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Statin Industry Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Statin Industry Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Statin Industry Market Share by Region (2021-2026) Table 4. Global Statin Industry Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Statin Industry Market Share by Region (2027-2032) Table 6. Global Statin Industry Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Statin Industry Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Statin Industry Market Size Share by Type (2021-2026) Table 9. Global Statin Industry Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Statin Industry Market Size Share Forecasted by Type (2027-2032) Table 11. North America Statin Industry Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Statin Industry Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Statin Industry Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Statin Industry Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Statin Industry Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Statin Industry Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Statin Industry Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Statin Industry Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Statin Industry Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Statin Industry Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Statin Industry Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Statin Industry Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Statin Industry Market Size Share by Application (2021-2026) Table 24. Global Statin Industry Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Statin Industry Market Size Share Forecasted by Application (2027-2032) Table 26. North America Statin Industry Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Statin Industry Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Statin Industry Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Statin Industry Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Statin Industry Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Statin Industry Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Statin Industry Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Statin Industry Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Statin Industry Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Statin Industry Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Statin Industry Industry Trends Table 37. Statin Industry Industry Drivers Table 38. Statin Industry Industry Opportunities and Challenges Table 39. Statin Industry Industry Restraints Table 40. Global Statin Industry Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Statin Industry Revenue Market Share by Company (2021-2026) Table 42. Global Statin Industry Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Statin Industry Key Company Headquarters & Area Served Table 44. Global Statin Industry Company, Product Type & Application Table 45. Global Statin Industry Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Statin Industry by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. CHIA TAI TIANQING Company Information Table 49. CHIA TAI TIANQING Business Overview Table 50. CHIA TAI TIANQING Statin Industry Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. CHIA TAI TIANQING Statin Industry Product Portfolio Table 52. CHIA TAI TIANQING Recent Development Table 53. Zhejiang Jingxin Pharmaceutical Company Information Table 54. Zhejiang Jingxin Pharmaceutical Business Overview Table 55. Zhejiang Jingxin Pharmaceutical Statin Industry Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Zhejiang Jingxin Pharmaceutical Statin Industry Product Portfolio Table 57. Zhejiang Jingxin Pharmaceutical Recent Development Table 58. Shanghai Shyndec Pharmaceutical Company Information Table 59. Shanghai Shyndec Pharmaceutical Business Overview Table 60. Shanghai Shyndec Pharmaceutical Statin Industry Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Shanghai Shyndec Pharmaceutical Statin Industry Product Portfolio Table 62. Shanghai Shyndec Pharmaceutical Recent Development Table 63. Henan Topfond Pharmaceutical Company Information Table 64. Henan Topfond Pharmaceutical Business Overview Table 65. Henan Topfond Pharmaceutical Statin Industry Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Henan Topfond Pharmaceutical Statin Industry Product Portfolio Table 67. Henan Topfond Pharmaceutical Recent Development Table 68. Novartis Company Information Table 69. Novartis Business Overview Table 70. Novartis Statin Industry Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Novartis Statin Industry Product Portfolio Table 72. Novartis Recent Development Table 73. Merck Company Information Table 74. Merck Business Overview Table 75. Merck Statin Industry Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Merck Statin Industry Product Portfolio Table 77. Merck Recent Development Table 78. LUNAN BETTER Company Information Table 79. LUNAN BETTER Business Overview Table 80. LUNAN BETTER Statin Industry Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. LUNAN BETTER Statin Industry Product Portfolio Table 82. LUNAN BETTER Recent Development Table 83. Livzon Pharmaceutical Company Information Table 84. Livzon Pharmaceutical Business Overview Table 85. Livzon Pharmaceutical Statin Industry Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Livzon Pharmaceutical Statin Industry Product Portfolio Table 87. Livzon Pharmaceutical Recent Development Table 88. Wanbang Biopharmaceuticals Company Information Table 89. Wanbang Biopharmaceuticals Business Overview Table 90. Wanbang Biopharmaceuticals Statin Industry Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Wanbang Biopharmaceuticals Statin Industry Product Portfolio Table 92. Wanbang Biopharmaceuticals Recent Development Table 93. Pfizer Company Information Table 94. Pfizer Business Overview Table 95. Pfizer Statin Industry Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Pfizer Statin Industry Product Portfolio Table 97. Pfizer Recent Development Table 98. Huizhi Company Information Table 99. Huizhi Business Overview Table 100. Huizhi Statin Industry Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Huizhi Statin Industry Product Portfolio Table 102. Huizhi Recent Development Table 103. China Resources Double-Crane Pharmaceutical Company Information Table 104. China Resources Double-Crane Pharmaceutical Business Overview Table 105. China Resources Double-Crane Pharmaceutical Statin Industry Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. China Resources Double-Crane Pharmaceutical Statin Industry Product Portfolio Table 107. China Resources Double-Crane Pharmaceutical Recent Development Table 108. North China Pharmaceutical Company Information Table 109. North China Pharmaceutical Business Overview Table 110. North China Pharmaceutical Statin Industry Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. North China Pharmaceutical Statin Industry Product Portfolio Table 112. North China Pharmaceutical Recent Development Table 113. Hanhui Pharmaceutical Company Information Table 114. Hanhui Pharmaceutical Business Overview Table 115. Hanhui Pharmaceutical Statin Industry Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Hanhui Pharmaceutical Statin Industry Product Portfolio Table 117. Hanhui Pharmaceutical Recent Development Table 118. Daiichi Sankyo Company Information Table 119. Daiichi Sankyo Business Overview Table 120. Daiichi Sankyo Statin Industry Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Daiichi Sankyo Statin Industry Product Portfolio Table 122. Daiichi Sankyo Recent Development Table 123. Beijing Jialin Pharmaceutical Company Information Table 124. Beijing Jialin Pharmaceutical Business Overview Table 125. Beijing Jialin Pharmaceutical Statin Industry Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Beijing Jialin Pharmaceutical Statin Industry Product Portfolio Table 127. Beijing Jialin Pharmaceutical Recent Development Table 128. AstraZeneca Company Information Table 129. AstraZeneca Business Overview Table 130. AstraZeneca Statin Industry Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. AstraZeneca Statin Industry Product Portfolio Table 132. AstraZeneca Recent Development Table 133. North America Statin Industry Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. North America Statin Industry Market Size by Country (2021-2026) & (US$ Million) Table 135. North America Statin Industry Market Share by Country (2021-2026) Table 136. North America Statin Industry Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. North America Statin Industry Market Share Forecast by Country (2027-2032) Table 138. Europe Statin Industry Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Europe Statin Industry Market Size by Country (2021-2026) & (US$ Million) Table 140. Europe Statin Industry Market Share by Country (2021-2026) Table 141. Europe Statin Industry Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Europe Statin Industry Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Statin Industry Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Statin Industry Market Size by Country (2021-2026) & (US$ Million) Table 145. Asia-Pacific Statin Industry Market Share by Country (2021-2026) Table 146. Asia-Pacific Statin Industry Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Asia-Pacific Statin Industry Market Share Forecast by Country (2027-2032) Table 148. Latin America Statin Industry Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Latin America Statin Industry Market Size by Country (2021-2026) & (US$ Million) Table 150. Latin America Statin Industry Market Share by Country (2021-2026) Table 151. Latin America Statin Industry Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Latin America Statin Industry Market Share Forecast by Country (2027-2032) Table 153. Middle East & Africa Statin Industry Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Middle East & Africa Statin Industry Market Size by Country (2021-2026) & (US$ Million) Table 155. Middle East & Africa Statin Industry Market Share by Country (2021-2026) Table 156. Middle East & Africa Statin Industry Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Middle East & Africa Statin Industry Market Share Forecast by Country (2027-2032) Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Statin Industry Product Image Figure 3. Global Statin Industry Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Statin Industry Market Size (2021-2032) & (US$ Million) Figure 5. Global Statin Industry Market Share by Region: 2025 VS 2032 Figure 6. Global Statin Industry Market Share by Region (2021-2032) Figure 7. North America Statin Industry Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Statin Industry Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Statin Industry Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Statin Industry Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Statin Industry Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Astrovastatin Image Figure 13. Global Astrovastatin Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Pitavastatin Image Figure 15. Global Pitavastatin Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Rosuvastatin Image Figure 17. Global Rosuvastatin Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Others Image Figure 19. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Statin Industry Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Statin Industry Market Share by Type 2025 VS 2032 Figure 22. North America Statin Industry Market Size Share by Type (2021-2032) Figure 23. Europe Statin Industry Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Statin Industry Market Size Share by Type (2021-2032) Figure 25. Latin America Statin Industry Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Statin Industry Market Size Share by Type (2021-2032) Figure 27. Inflammatory Disorders Image Figure 28. Global Inflammatory Disorders Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Cardiovascular Disorders Image Figure 30. Global Cardiovascular Disorders Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Obesity Image Figure 32. Global Obesity Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Others Image Figure 34. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Statin Industry Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Statin Industry Market Share by Application 2025 VS 2032 Figure 37. North America Statin Industry Market Size Share by Application (2021-2032) Figure 38. Europe Statin Industry Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Statin Industry Market Size Share by Application (2021-2032) Figure 40. Latin America Statin Industry Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Statin Industry Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Statin Industry Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Statin Industry Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Statin Industry Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Statin Industry Market Share by Country (2021-2032) Figure 47. Europe Statin Industry Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Statin Industry Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Statin Industry Market Share by Country (2021-2032) Figure 50. Asia-Pacific Statin Industry Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Statin Industry Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Statin Industry Market Share by Country (2021-2032) Figure 53. Latin America Statin Industry Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Statin Industry Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Statin Industry Market Share by Country (2021-2032) Figure 56. Middle East & Africa Statin Industry Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Statin Industry Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Statin Industry Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • Astrovastatin
  • Pitavastatin
  • Rosuvastatin
  • Others
Applications
  • Inflammatory Disorders
  • Cardiovascular Disorders
  • Obesity
  • Others
Companies covered
  • CHIA TAI TIANQING
  • Zhejiang Jingxin Pharmaceutical
  • Shanghai Shyndec Pharmaceutical
  • Henan Topfond Pharmaceutical
  • Novartis
  • Merck
  • LUNAN BETTER
  • Livzon Pharmaceutical
  • Wanbang Biopharmaceuticals
  • Pfizer
  • Huizhi
  • China Resources Double-Crane Pharmaceutical
  • North China Pharmaceutical
  • Hanhui Pharmaceutical
  • Daiichi Sankyo
  • Beijing Jialin Pharmaceutical
  • AstraZeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Statin Industry Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Statin Industry Market Size by Region (2021-2032)
  5. 1.4.1 Global Statin Industry Market Size by Region (2021-2026)
  6. 1.4.2 Global Statin Industry Market Size by Region (2027-2032)
  7. 1.5 Key Regions Statin Industry Market Size (2021-2032)
  8. 1.5.1 North America Statin Industry Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Statin Industry Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Statin Industry Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Statin Industry Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Statin Industry Market Size Growth Rate (2021-2032)
2 Statin Industry Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Astrovastatin
  3. 2.1.2 Pitavastatin
  4. 2.1.3 Rosuvastatin
  5. 2.1.4 Others
  6. 2.2 Global Statin Industry Market Size by Type
  7. 2.2.1 Global Statin Industry Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Statin Industry Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Statin Industry Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Statin Industry Market Size by Regions
  11. 2.3.1 North America Statin Industry Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Statin Industry Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Statin Industry Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Statin Industry Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Statin Industry Market Size Breakdown by Type (2021-2026)
3 Statin Industry Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Inflammatory Disorders
  3. 3.1.2 Cardiovascular Disorders
  4. 3.1.3 Obesity
  5. 3.1.4 Others
  6. 3.2 Global Statin Industry Market Size by Application
  7. 3.2.1 Global Statin Industry Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Statin Industry Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Statin Industry Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Statin Industry Market Size by Regions
  11. 3.3.1 North America Statin Industry Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Statin Industry Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Statin Industry Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Statin Industry Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Statin Industry Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Statin Industry Industry Trends
  2. 4.2 Statin Industry Industry Drivers
  3. 4.3 Statin Industry Industry Opportunities and Challenges
  4. 4.4 Statin Industry Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Statin Industry Revenue (2021-2026)
  2. 5.2 Global Statin Industry Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Statin Industry Key Company Headquarters & Area Served
  4. 5.4 Global Statin Industry Company, Product Type & Application
  5. 5.5 Global Statin Industry Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Statin Industry Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Statin Industry Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Statin Industry Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 CHIA TAI TIANQING
  2. 6.1.1 CHIA TAI TIANQING Company Information
  3. 6.1.2 CHIA TAI TIANQING Business Overview
  4. 6.1.3 CHIA TAI TIANQING Statin Industry Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 CHIA TAI TIANQING Statin Industry Product Portfolio
  6. 6.1.5 CHIA TAI TIANQING Recent Developments
  7. 6.2 Zhejiang Jingxin Pharmaceutical
  8. 6.2.1 Zhejiang Jingxin Pharmaceutical Company Information
  9. 6.2.2 Zhejiang Jingxin Pharmaceutical Business Overview
  10. 6.2.3 Zhejiang Jingxin Pharmaceutical Statin Industry Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Zhejiang Jingxin Pharmaceutical Statin Industry Product Portfolio
  12. 6.2.5 Zhejiang Jingxin Pharmaceutical Recent Developments
  13. 6.3 Shanghai Shyndec Pharmaceutical
  14. 6.3.1 Shanghai Shyndec Pharmaceutical Company Information
  15. 6.3.2 Shanghai Shyndec Pharmaceutical Business Overview
  16. 6.3.3 Shanghai Shyndec Pharmaceutical Statin Industry Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Shanghai Shyndec Pharmaceutical Statin Industry Product Portfolio
  18. 6.3.5 Shanghai Shyndec Pharmaceutical Recent Developments
  19. 6.4 Henan Topfond Pharmaceutical
  20. 6.4.1 Henan Topfond Pharmaceutical Company Information
  21. 6.4.2 Henan Topfond Pharmaceutical Business Overview
  22. 6.4.3 Henan Topfond Pharmaceutical Statin Industry Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Henan Topfond Pharmaceutical Statin Industry Product Portfolio
  24. 6.4.5 Henan Topfond Pharmaceutical Recent Developments
  25. 6.5 Novartis
  26. 6.5.1 Novartis Company Information
  27. 6.5.2 Novartis Business Overview
  28. 6.5.3 Novartis Statin Industry Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Novartis Statin Industry Product Portfolio
  30. 6.5.5 Novartis Recent Developments
  31. 6.6 Merck
  32. 6.6.1 Merck Company Information
  33. 6.6.2 Merck Business Overview
  34. 6.6.3 Merck Statin Industry Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Merck Statin Industry Product Portfolio
  36. 6.6.5 Merck Recent Developments
  37. 6.7 LUNAN BETTER
  38. 6.7.1 LUNAN BETTER Company Information
  39. 6.7.2 LUNAN BETTER Business Overview
  40. 6.7.3 LUNAN BETTER Statin Industry Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 LUNAN BETTER Statin Industry Product Portfolio
  42. 6.7.5 LUNAN BETTER Recent Developments
  43. 6.8 Livzon Pharmaceutical
  44. 6.8.1 Livzon Pharmaceutical Company Information
  45. 6.8.2 Livzon Pharmaceutical Business Overview
  46. 6.8.3 Livzon Pharmaceutical Statin Industry Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Livzon Pharmaceutical Statin Industry Product Portfolio
  48. 6.8.5 Livzon Pharmaceutical Recent Developments
  49. 6.9 Wanbang Biopharmaceuticals
  50. 6.9.1 Wanbang Biopharmaceuticals Company Information
  51. 6.9.2 Wanbang Biopharmaceuticals Business Overview
  52. 6.9.3 Wanbang Biopharmaceuticals Statin Industry Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Wanbang Biopharmaceuticals Statin Industry Product Portfolio
  54. 6.9.5 Wanbang Biopharmaceuticals Recent Developments
  55. 6.10 Pfizer
  56. 6.10.1 Pfizer Company Information
  57. 6.10.2 Pfizer Business Overview
  58. 6.10.3 Pfizer Statin Industry Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Pfizer Statin Industry Product Portfolio
  60. 6.10.5 Pfizer Recent Developments
  61. 6.11 Huizhi
  62. 6.11.1 Huizhi Company Information
  63. 6.11.2 Huizhi Business Overview
  64. 6.11.3 Huizhi Statin Industry Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Huizhi Statin Industry Product Portfolio
  66. 6.11.5 Huizhi Recent Developments
  67. 6.12 China Resources Double-Crane Pharmaceutical
  68. 6.12.1 China Resources Double-Crane Pharmaceutical Company Information
  69. 6.12.2 China Resources Double-Crane Pharmaceutical Business Overview
  70. 6.12.3 China Resources Double-Crane Pharmaceutical Statin Industry Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 China Resources Double-Crane Pharmaceutical Statin Industry Product Portfolio
  72. 6.12.5 China Resources Double-Crane Pharmaceutical Recent Developments
  73. 6.13 North China Pharmaceutical
  74. 6.13.1 North China Pharmaceutical Company Information
  75. 6.13.2 North China Pharmaceutical Business Overview
  76. 6.13.3 North China Pharmaceutical Statin Industry Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 North China Pharmaceutical Statin Industry Product Portfolio
  78. 6.13.5 North China Pharmaceutical Recent Developments
  79. 6.14 Hanhui Pharmaceutical
  80. 6.14.1 Hanhui Pharmaceutical Company Information
  81. 6.14.2 Hanhui Pharmaceutical Business Overview
  82. 6.14.3 Hanhui Pharmaceutical Statin Industry Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Hanhui Pharmaceutical Statin Industry Product Portfolio
  84. 6.14.5 Hanhui Pharmaceutical Recent Developments
  85. 6.15 Daiichi Sankyo
  86. 6.15.1 Daiichi Sankyo Company Information
  87. 6.15.2 Daiichi Sankyo Business Overview
  88. 6.15.3 Daiichi Sankyo Statin Industry Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Daiichi Sankyo Statin Industry Product Portfolio
  90. 6.15.5 Daiichi Sankyo Recent Developments
  91. 6.16 Beijing Jialin Pharmaceutical
  92. 6.16.1 Beijing Jialin Pharmaceutical Company Information
  93. 6.16.2 Beijing Jialin Pharmaceutical Business Overview
  94. 6.16.3 Beijing Jialin Pharmaceutical Statin Industry Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Beijing Jialin Pharmaceutical Statin Industry Product Portfolio
  96. 6.16.5 Beijing Jialin Pharmaceutical Recent Developments
  97. 6.17 AstraZeneca
  98. 6.17.1 AstraZeneca Company Information
  99. 6.17.2 AstraZeneca Business Overview
  100. 6.17.3 AstraZeneca Statin Industry Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 AstraZeneca Statin Industry Product Portfolio
  102. 6.17.5 AstraZeneca Recent Developments
7 North America
  1. 7.1 North America Statin Industry Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Statin Industry Market Size by Country (2021-2026)
  3. 7.3 North America Statin Industry Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Statin Industry Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Statin Industry Market Size by Country (2021-2026)
  3. 8.3 Europe Statin Industry Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Statin Industry Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Statin Industry Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Statin Industry Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Statin Industry Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Statin Industry Market Size by Country (2021-2026)
  3. 10.3 South America Statin Industry Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Statin Industry Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Statin Industry Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Statin Industry Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst